Skip to main content
Erschienen in:

26.11.2021 | Original Article

Nationwide mammographic screening and breast cancer mortality in Taiwan: an interrupted time-series analysis

verfasst von: Shih-Yung Su

Erschienen in: Breast Cancer | Ausgabe 2/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

In Taiwan, breast cancer is the third leading cause of cancer death in women. A nationwide screening program with biennial mammography for women aged 40–69 in Taiwan was implemented since July 2004, but the impact on breast cancer mortality has not been investigated.

Methods

The interrupted time-series analysis was used to estimate the impact of mammographic screening on temporal trends of breast cancer mortality and to calculate the level of temporal changes due to the mammographic screening.

Results

The annual average percentage changes of the age-standardized breast cancer mortality rates for all women aged 40–69 were 1.06% from 1991 to 2004 (before mammographic screening) and 0.33–0.34% from 2005 to 2019 (after mammographic screening). For all women aged 40–69, the results of interrupted time-series analysis showed that the increasing trends of breast cancer mortality were all attenuated after the implementation of mammographic screening. An estimation of 2114 women prevented from death of breast cancer may be attributable to screening. For women aged 40–44, 55–59, 60–64 and 65–69, the percentage changes in mortality rates were − 12.1% (− 5.1 to − 19.6%), − 20.8% (− 16.5 to − 25.2%), − 12.8% (− 8.5 to − 17.3%) and − 13.0% (− 7.9 to − 18.3%), respectively, after screening. For women aged 45–49 and 50–54, the reduction of deaths and mortality rates of breast cancer were a little.

Conclusions

This study revealed that the nationwide screening program with biennial mammography may be associated with the attenuation of breast cancer mortality trends in women aged 40–69 in Taiwan.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Wild CP, Weiderpass E, Stewart BW, editors. World cancer report: cancer research for cancer prevention. Lyon: International Agency for Research on Cancer; 2020. Wild CP, Weiderpass E, Stewart BW, editors. World cancer report: cancer research for cancer prevention. Lyon: International Agency for Research on Cancer; 2020.
4.
Zurück zum Zitat Loberg M, Lousdal ML, Bretthauer M, Kalager M. Benefits and harms of mammography screening. Breast Cancer Res. 2015;17:63.CrossRef Loberg M, Lousdal ML, Bretthauer M, Kalager M. Benefits and harms of mammography screening. Breast Cancer Res. 2015;17:63.CrossRef
5.
Zurück zum Zitat Wilkinson L, Thomas V, Sharma N. Microcalcification on mammography: approaches to interpretation and biopsy. Br J Radiol. 2017;90(1069):20160594.CrossRef Wilkinson L, Thomas V, Sharma N. Microcalcification on mammography: approaches to interpretation and biopsy. Br J Radiol. 2017;90(1069):20160594.CrossRef
6.
Zurück zum Zitat Johns LE, Coleman DA, Swerdlow AJ, Moss SM. Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: an individual-level cohort study. Br J Cancer. 2017;116(2):246–52.CrossRef Johns LE, Coleman DA, Swerdlow AJ, Moss SM. Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: an individual-level cohort study. Br J Cancer. 2017;116(2):246–52.CrossRef
7.
Zurück zum Zitat Morrell S, Taylor R, Roder D, Robson B, Gregory M, Craig K. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999–2011. Br J Cancer. 2017;116(6):828–39.CrossRef Morrell S, Taylor R, Roder D, Robson B, Gregory M, Craig K. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999–2011. Br J Cancer. 2017;116(6):828–39.CrossRef
8.
Zurück zum Zitat Sankatsing VDV, van Ravesteyn NT, Heijnsdijk EAM, Looman CWN, van Luijt PA, Fracheboud J, den Heeten GJ, Broeders MJM, de Koning HJ. The effect of population-based mammography screening in Dutch municipalities on breast cancer mortality: 20 years of follow-up. Int J Cancer. 2017;141(4):671–7.CrossRef Sankatsing VDV, van Ravesteyn NT, Heijnsdijk EAM, Looman CWN, van Luijt PA, Fracheboud J, den Heeten GJ, Broeders MJM, de Koning HJ. The effect of population-based mammography screening in Dutch municipalities on breast cancer mortality: 20 years of follow-up. Int J Cancer. 2017;141(4):671–7.CrossRef
9.
Zurück zum Zitat Verdial FC, Etzioni R, Duggan C, Anderson BO. Demographic changes in breast cancer incidence, stage at diagnosis and age associated with population-based mammographic screening. J Surg Oncol. 2017;115(5):517–22.CrossRef Verdial FC, Etzioni R, Duggan C, Anderson BO. Demographic changes in breast cancer incidence, stage at diagnosis and age associated with population-based mammographic screening. J Surg Oncol. 2017;115(5):517–22.CrossRef
10.
Zurück zum Zitat Van Ourti T, O’Donnell O, Koc H, Fracheboud J, de Koning HJ. Effect of screening mammography on breast cancer mortality: Quasi-experimental evidence from rollout of the Dutch population-based program with 17-year follow-up of a cohort. Int J Cancer. 2020;146(8):2201–8.CrossRef Van Ourti T, O’Donnell O, Koc H, Fracheboud J, de Koning HJ. Effect of screening mammography on breast cancer mortality: Quasi-experimental evidence from rollout of the Dutch population-based program with 17-year follow-up of a cohort. Int J Cancer. 2020;146(8):2201–8.CrossRef
11.
Zurück zum Zitat Katalinic A, Eisemann N, Kraywinkel K, Noftz MR, Hubner J. Breast cancer incidence and mortality before and after implementation of the German mammography screening program. Int J Cancer. 2020;147(3):709–18.CrossRef Katalinic A, Eisemann N, Kraywinkel K, Noftz MR, Hubner J. Breast cancer incidence and mortality before and after implementation of the German mammography screening program. Int J Cancer. 2020;147(3):709–18.CrossRef
12.
Zurück zum Zitat Ho ML, Hsiao YH, Su SY, Chou MC, Liaw YP. Mortality of breast cancer in Taiwan, 1971–2010: temporal changes and an age-period-cohort analysis. J Obstet Gynaecol. 2015;35(1):60–3.CrossRef Ho ML, Hsiao YH, Su SY, Chou MC, Liaw YP. Mortality of breast cancer in Taiwan, 1971–2010: temporal changes and an age-period-cohort analysis. J Obstet Gynaecol. 2015;35(1):60–3.CrossRef
13.
Zurück zum Zitat Bernal JL, Cummins S, Gasparrini A. Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol. 2017;46(1):348–55.PubMed Bernal JL, Cummins S, Gasparrini A. Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol. 2017;46(1):348–55.PubMed
14.
Zurück zum Zitat Lopez Bernal J, Soumerai S, Gasparrini A. A methodological framework for model selection in interrupted time series studies. J Clin Epidemiol. 2018;103:82–91.CrossRef Lopez Bernal J, Soumerai S, Gasparrini A. A methodological framework for model selection in interrupted time series studies. J Clin Epidemiol. 2018;103:82–91.CrossRef
16.
Zurück zum Zitat Maurice A, Evans DG, Shenton A, Ashcroft L, Baildam A, Barr L, Byrne G, Bundred N, Boggis C, Wilson M, et al. Screening younger women with a family history of breast cancer–does early detection improve outcome? Eur J Cancer. 2006;42(10):1385–90.CrossRef Maurice A, Evans DG, Shenton A, Ashcroft L, Baildam A, Barr L, Byrne G, Bundred N, Boggis C, Wilson M, et al. Screening younger women with a family history of breast cancer–does early detection improve outcome? Eur J Cancer. 2006;42(10):1385–90.CrossRef
17.
Zurück zum Zitat Yen AM, Tsau HS, Fann JC, Chen SL, Chiu SY, Lee YC, Pan SL, Chiu HM, Kuo WH, Chang KJ, et al. Population-based breast cancer screening with risk-based and universal mammography screening compared with clinical breast examination: a propensity score analysis of 1429890 Taiwanese women. JAMA Oncol. 2016;2(7):915–21.CrossRef Yen AM, Tsau HS, Fann JC, Chen SL, Chiu SY, Lee YC, Pan SL, Chiu HM, Kuo WH, Chang KJ, et al. Population-based breast cancer screening with risk-based and universal mammography screening compared with clinical breast examination: a propensity score analysis of 1429890 Taiwanese women. JAMA Oncol. 2016;2(7):915–21.CrossRef
18.
Zurück zum Zitat Chiang CJ, Lo WC, Yang YW, You SL, Chen CJ, Lai MS. Incidence and survival of adult cancer patients in Taiwan, 2002–2012. J Formos Med Assoc. 2016;115(12):1076–88.CrossRef Chiang CJ, Lo WC, Yang YW, You SL, Chen CJ, Lai MS. Incidence and survival of adult cancer patients in Taiwan, 2002–2012. J Formos Med Assoc. 2016;115(12):1076–88.CrossRef
19.
Zurück zum Zitat Suzuki A, Kuriyama S, Kawai M, Amari M, Takeda M, Ishida T, Ohnuki K, Nishino Y, Tsuji I, Shibuya D, et al. Age-specific interval breast cancers in Japan: estimation of the proper sensitivity of screening using a population-based cancer registry. Cancer Sci. 2008;99(11):2264–7.CrossRef Suzuki A, Kuriyama S, Kawai M, Amari M, Takeda M, Ishida T, Ohnuki K, Nishino Y, Tsuji I, Shibuya D, et al. Age-specific interval breast cancers in Japan: estimation of the proper sensitivity of screening using a population-based cancer registry. Cancer Sci. 2008;99(11):2264–7.CrossRef
20.
Zurück zum Zitat Ohuchi N, Suzuki A, Sobue T, Kawai M, Yamamoto S, Zheng YF, Shiono YN, Saito H, Kuriyama S, Tohno E, et al. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet. 2016;387(10016):341–8.CrossRef Ohuchi N, Suzuki A, Sobue T, Kawai M, Yamamoto S, Zheng YF, Shiono YN, Saito H, Kuriyama S, Tohno E, et al. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet. 2016;387(10016):341–8.CrossRef
21.
Zurück zum Zitat Harada-Shoji N, Suzuki A, Ishida T, Zheng YF, Narikawa-Shiono Y, Sato-Tadano A, Ohta R, Ohuchi N. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40–49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Netw Open. 2021;4(8):1505.CrossRef Harada-Shoji N, Suzuki A, Ishida T, Zheng YF, Narikawa-Shiono Y, Sato-Tadano A, Ohta R, Ohuchi N. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40–49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Netw Open. 2021;4(8):1505.CrossRef
23.
Zurück zum Zitat Seiffert K, Thoene K, Eulenburg CZ, Behrens S, Schmalfeldt B, Becher H, Chang-Claude J, Witzel I. The effect of family history on screening procedures and prognosis in breast cancer patients: results of a large population-based case-control study. Breast. 2021;55:98–104.CrossRef Seiffert K, Thoene K, Eulenburg CZ, Behrens S, Schmalfeldt B, Becher H, Chang-Claude J, Witzel I. The effect of family history on screening procedures and prognosis in breast cancer patients: results of a large population-based case-control study. Breast. 2021;55:98–104.CrossRef
Metadaten
Titel
Nationwide mammographic screening and breast cancer mortality in Taiwan: an interrupted time-series analysis
verfasst von
Shih-Yung Su
Publikationsdatum
26.11.2021
Verlag
Springer Singapore
Erschienen in
Breast Cancer / Ausgabe 2/2022
Print ISSN: 1340-6868
Elektronische ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-021-01315-z

Neu im Fachgebiet Onkologie

Studie zur HIFU bei Prostatakrebs lässt viele Fragen offen

Führt eine HIFU-Ablation beim Prostatakarzinom im Vergleich mit einer radikalen Prostatektomie zu ähnlichen onkologischen, aber besseren funktionalen Ergebnissen? Interimsdaten der französischen HIFI-Studie sind uneindeutig. In einem Kommentar zur Studie werden zumindest drei allgemeine Erkenntnisse herausgearbeitet.

Bei Achalasie auf Candidiasis der Speiseröhre achten!

Bei Achalasie-Betroffenen sollte man immer auch auf Candida-Infektionen achten, warnen Forschende aus Rotterdam. In ihrer Studie ließ die Pilzinfektion das Risiko für ein Ösophaguskarzinom massiv steigen.

Adipositas als negativer Prognosefaktor bei Kindern mit Krebs

Eine kanadische Studie weist darauf hin, dass Übergewicht zum Zeitpunkt der Krebsdiagnose ein unabhängiger Risikofaktor für schlechtere Überlebenschancen bei erkrankten Kindern und Jugendlichen sein könnte. Allerdings sind nicht alle Patientinnen und Patienten gleichermaßen betroffen.


Polypen bei nahen Verwandten – erhöhtes Darmkrebsrisiko

Werden bei erstgradigen Verwandten gutartige Darmpolypen identifiziert, ist das Risiko, selbst an einem Kolorektalkarzinom zu erkranken, deutlich erhöht – vor allem das für eine früh beginnende Erkrankung. Hier könnte sich eine frühe Koloskopie besonders lohnen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.